SOUTH PLAINFIELD, N.J.,
Oct. 19, 2017 /PRNewswire/
-- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that
the Company will host a webcast conference call to report its third
quarter financial results and provide an update on the company's
business and outlook on Thursday, November
2, 2017 at 4:30 p.m. (ET)
after the closing of the market.
The call can be accessed by dialing (877) 303-9216 (domestic) or
(973) 935-8152 (international) five minutes prior to the start of
the call and providing the passcode 2261347. A live, listen-only
webcast of the conference call can be accessed on the investor
relations section of the PTC website at www.ptcbio.com. A webcast
replay of the call will be available approximately two hours after
completion of the call and will be archived on the company's
website for two weeks.
About PTC Therapeutics, Inc.
PTC is a global
biopharmaceutical company focused on the discovery, development,
and commercialization of novel medicines using our expertise in RNA
biology. PTC's internally discovered pipeline addresses multiple
therapeutic areas, including rare disorders and oncology. PTC has
discovered all of its compounds currently under development using
its proprietary technologies. Since its founding nearly 20 years
ago, PTC's mission has focused on developing treatments to
fundamentally change the lives of patients living with rare genetic
disorders. The company was founded in 1998 and is headquartered in
South Plainfield, New Jersey. For
more information on the company, please visit our website
www.ptcbio.com.
For More
Information Please Contact:
|
Media:
|
Investors:
|
Jane Baj
|
Emily Hill
|
+1 (908)
912-9167
|
+1 (908)
912-9327
|
jbaj@ptcbio.com
|
ehill@ptcbio.com
|
View original
content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-financial-results-300539550.html
SOURCE PTC Therapeutics, Inc.